CompletedPhase 1NCT00767364

Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome

Studying Short bowel syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital of Michigan
Principal Investigator
Eric J McGrath, MD
Children's Hospital of Michigan
Intervention
Oral, live, pentavalent rotavirus vaccine; RotaTeq(R)(biological)
Enrollment
8 enrolled
Eligibility
All sexes
Timeline
2009 – 2013

Study locations (3)

Collaborators

Merck Sharp & Dohme LLC · Corewell Health East · Boston Children's Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00767364 on ClinicalTrials.gov

Other trials for Short bowel syndrome

Additional recruiting or active studies for the same condition.

See all trials for Short bowel syndrome →

← Back to all trials